Roche logo

Roche Chugai bid planned

Published: 04:33, August 16, 2014

A Roche Chugai bid is set to occur, twelve years after the Swiss pharmaceutical giant paid $1.4 billion for a 50.1% stake in the Japanese drugmaker. With an expected $10 billion offer, Roche, which plans to expand in Asia, would own the whole company.

In 2008, Roche increased its stake in Chugai Pharmaceutical Co., Ltd. to 59.9%.

Bloomberg quotes unnamed people familiar with the situation who believe a deal will be announced next week.

Roche, a busy summer

During the last three months, Roche, the world’s largest maker of cancer medications, has reached deals with:

  • Seragon Pharmaceuticals: The deal includes an up-front cash payment of $725 million plus $1 billion when certain targets are reached. Of interest was its experimental next-generation oral selective estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer. The company was bought by Roche’s subsidiary company Genentech.
  • Santaris Pharma: $250 million plus up to $200 million when certain targets are met. Roche wanted Santaris’ proprietary LNA (Locked Nucleic Acid) platform that has contributed to an emerging era of RNA-targeting therapeutics.
  • Genia Techologies Inc.: $125 million plus up to $225 million when targets are met. The California-based company is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore technology.

For Roche, 2014 has been its busiest period for acquisitions since it took over San Francisco-based Genentech in 2009 for $47 billion.

Chugai, which specializes in arthritis and cancer medications, posted sales of $4.4 billion in 2013, compared to Roche’s $52 billion (group sales 46.7 Swiss francs).

Roche Chugai

The two companies jointly sell Tarceva (lung and pancreatic cancers), Herceptin (breast and gastric cancers) and Avastin (several cancers). They are also developing the rheumatoid medication Actemra together.

Chugai move a surprise

Roche’s CEO, Severin Schwan, said last year that he could not see any reason to acquire the rest of Chugai. In July this year, he said the company would carry on with its strategy of small, targeted acquisitions and partnerships.

In 2013, Roche generated almost $19 billion of free cash flow. It is predicted to be in a net cash position by the end of this year.

There were rumors that Roche might place offers for Alexion ($20 billion) and BioMarin ($13.5 billion), both rare disease specialists, but nothing came from them.

Roche’s motive for acquiring the rest of Chugai has more to do with consolidating its position in an expanding Asian market than extending its portfolio of medications.

Christian Nordqvist Avatar

Other News

A digital product passport changed toothbrush valuations in a lab study

Nov 22, 2026

Purchase-linked donations can change direct giving in a small experiment

Nov 22, 2026

Volunteer recruitment emails were followed by more donations in a nonprofit experiment

Nov 22, 2026

Customer-created content was linked to brand perceptions in a survey of Pakistani shoppers

Nov 22, 2026

Shopping games can frustrate customers when rewards and rules are hard to understand

Nov 22, 2026

Text-message business training helped Kenyan entrepreneurs briefly, but gains faded

Nov 22, 2026

Food traceability labels raised stated interest, but ad test found no clear difference

Nov 22, 2026

Letting shoppers keep an item for a partial refund lifted later spending in a field experiment

Nov 22, 2026

Skincare claims that look scientific changed shopping choices in an online experiment

Nov 21, 2026

Crowded settings can make unfamiliar products less appealing in consumer experiments

Nov 21, 2026

Words that describe texture can affect online clothing choices, study finds

Nov 21, 2026

Impact measurement support helped Indian social enterprises grow in a field experiment

Nov 21, 2026

Lyft experiment found a premium ride option shifted some customers to cheaper fares

Nov 21, 2026

Online retailer improved pricing by testing how shoppers respond to rivals

Nov 21, 2026

Environmental reminders reduced return shipments in a fashion retailer experiment

Nov 21, 2026

When a discount is hard to claim, it can reduce sales of the product

Nov 20, 2026

A small step to claim a discount increased redemptions in a coffee campaign

Nov 20, 2026

Ad platforms can target likely buyers without creating the most extra sales

Nov 20, 2026

Sales contests worked better when employees competed in comparable groups

Nov 20, 2026

Social discounts encouraged existing grocery customers to buy more in an experiment

Nov 20, 2026